期刊
DIABETES
卷 66, 期 6, 页码 1535-1547出版社
AMER DIABETES ASSOC
DOI: 10.2337/db16-1354
关键词
-
资金
- National Natural Science Foundation of China [31671181, 31371153, 31171133]
- Science and Technology Commission of Shanghai Municipality [15140904400]
- Accelerating Excellence in Translational Science Pilot grant [G0812D05]
- National Institutes of Health (National Cancer Institute, National Institute on Minority Health and Health Disparities) [U54 CA143931, U54MD0075984]
- National Institutes of Health/National Cancer Institute [SC1CA200517]
- Shanghai Summit & Plateau Discipline Developing Projects
Although the importance of macrophages in nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) has been recognized, how macrophages affect hepatocytes remains elusive. Mineralocorticoid receptor (MR) has been implicated to play important roles in NAFLD and T2DM. However, cellular and molecular mechanisms are largely unknown. We report that myeloid MR knockout (MRKO) improves glucose intolerance, insulin resistance, and hepatic steatosis in obese mice. Estrogen signaling is sufficient and necessary for such improvements. Hepatic gene and protein expression suggests that MRKO reduces hepatic lipogenesis and lipid storage. In the presence of estrogen, MRKO in macrophages decreases lipid accumulation and increases insulin sensitivity of hepatocytes through hepatocyte growth factor (HGF)/Met signaling. MR directly regulates estrogen receptor 1 (Esr1 [encoding ER]) in macrophages. Knockdown of hepatic Met eliminates the beneficial effects of MRKO in female obese mice. These findings identify a novel MR/ER/HGF/Met pathway that conveys metabolic signaling from macrophages to hepatocytes in hepatic steatosis and insulin resistance and provide potential new therapeutic strategies for NAFLD and T2DM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据